2021
DOI: 10.1007/s13105-021-00850-9
|View full text |Cite
|
Sign up to set email alerts
|

Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(10 citation statements)
references
References 111 publications
2
8
0
Order By: Relevance
“…On the other hand, these metabolic results indirectly suggested that the improvements in muscle function with AX supplementation were not solely dependent on changes in body fat. Food intake did not significantly differ between the HFD and AX groups in this study, consistent with previous studies that displayed anti-obesity effects of AX in animal models fed a HFD without effecting food and calorie intake [ 68 , 69 , 70 ]. Mechanisms included inhibiting lipogenesis, promoting lipolysis and enhancing the antioxidant system [ 69 , 70 ].…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…On the other hand, these metabolic results indirectly suggested that the improvements in muscle function with AX supplementation were not solely dependent on changes in body fat. Food intake did not significantly differ between the HFD and AX groups in this study, consistent with previous studies that displayed anti-obesity effects of AX in animal models fed a HFD without effecting food and calorie intake [ 68 , 69 , 70 ]. Mechanisms included inhibiting lipogenesis, promoting lipolysis and enhancing the antioxidant system [ 69 , 70 ].…”
Section: Discussionsupporting
confidence: 92%
“…Food intake did not significantly differ between the HFD and AX groups in this study, consistent with previous studies that displayed anti-obesity effects of AX in animal models fed a HFD without effecting food and calorie intake [ 68 , 69 , 70 ]. Mechanisms included inhibiting lipogenesis, promoting lipolysis and enhancing the antioxidant system [ 69 , 70 ]. Ren et al found that AX assisted in slowing skeletal muscle atrophy in H22 tumor-bearing mice, without effecting food intake [ 51 ].…”
Section: Discussionsupporting
confidence: 92%
“…The selected doses of DOX and BBR, as well as the design of the experiment were selected in accordance with the study of Fouad et al, 44 which reported an antioxidant protection of BBR, at this dose, in DOX rat model. The in vivo administration of brusatol at this dose to block hepatic Nrf2 has been reported by Shatoor et al 46…”
Section: Selection Of Drug Dosesmentioning
confidence: 66%
“…Zingerone at the selected dose (1/10 or the LD50) was shown to be a therapeutic dose in rats that protected against HFD-induced NAFLD and hepatic oxidative damage, alloxan-induced diabetic complications, inflammation, oxidative stress, ethanol-induced gastric ulcer, carbon tetrachloride (CCl4)-induced nephropathy ( Ahmad et al, 2018 , Safhi, 2018 ). The regimen of brusatol was used by many authors to suppress tissue activation of Nrf2 in vivo ( Bovilla et al, 2021 , Shatoor et al, 2021 ).…”
Section: Methodsmentioning
confidence: 99%